Minimally invasive 'step-up approach' versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN13975868].
BACKGROUND: The initial treatment of acute necrotizing pancreatitis is conservative. Intervention is indicated in patients with (suspected) infected necrotizing pancreatitis. In the Netherlands, the standard intervention is necrosectomy by laparotomy followed by continuous postoperative lavage (CPL...
Auteurs principaux: | Besselink, MG, van Santvoort, H, Nieuwenhuijs, V, Boermeester, M, Bollen, T, Buskens, E, Dejong, C, Eijck, v, van Goor, H, Hofker, S, Lameris, J, van Leeuwen, MS, Ploeg, R, van Ramshorst, B, Schaapherder, A, Cuesta, M, Consten, E, Gouma, D, van der Harst, E, Hesselink, E, Houdijk, L, Karsten, T, van Laarhoven, C, Pierie, J, Rosman, C |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2006
|
Documents similaires
-
Minimally invasive 'step-up approach' versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN13975868]
par: Besselink, M, et autres
Publié: (2006) -
Minimally invasive 'step-up approach' versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN13975868]
par: Houdijk Lex PJ, et autres
Publié: (2006-04-01) -
[Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial].
par: Besselink, MG, et autres
Publié: (2008) -
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.
par: Besselink, MG, et autres
Publié: (2008) -
Probiotic prophylaxis in patients with predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial
par: Besselink, M, et autres
Publié: (2008)